Phase 4 Amyloid Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
Transthyretin Amyloid Cardiomyopathy
Bayer50 enrolled10 locationsNCT07298044
Recruiting
Phase 4
Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Transthyretin-type Cardiac Amyloidosis
Alexion Pharmaceuticals, Inc.200 enrolled16 locationsNCT07306949
Recruiting
Phase 4
Ultrasound Therapy In Cardiac Amyloidosis
Amyloidosis Cardiac
Brigham and Women's Hospital70 enrolled1 locationNCT04667494
Recruiting
Phase 4
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
Transthyretin Cardiac Amyloidosis
University of Texas Southwestern Medical Center25 enrolled4 locationsNCT05489523
Recruiting
Phase 4
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Primary Cutaneous Amyloidosis
Army Medical University, China56 enrolled1 locationNCT06998875
Recruiting
Phase 4
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Transthyretin Amyloid Polyneuropathy
Qilu Pharmaceutical Co., Ltd.15 enrolled1 locationNCT06940336
Recruiting
Phase 4
Clinical Study of ATTR-CM
Transthyroxine Amyloidosis Cardiomyopathy
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT04935021